Catch-up HPV vaccination for men to prevent throat cancer
HPV throat cancer now exceeds cervical cancer in some countries and mostly affects men, who were not vaccinated. Vaccinating men up to 45 could reduce it.
HPV vaccination reduces oral HPV16 prevalence, and oropharyngeal cancer incidence in men is rising. Propose catch-up vaccination for men to age 45, with oral HPV prevalence as an intermediate endpoint and modelled cancer reduction.
- Prevention we already have is not deployed · Around four in ten cancers are preventable with tools we already own: vaccines, tobacco control, weight, alcohol, sun and infection control.
Pages like this
not linked directly; found by shared links- IdeaOffer HPV vaccination to women when they come for cervical screening or treatment
Shares England's HPV programme: cervical cancer down 87% in the first cohort vaccinated at 12-13, HPV & HBV vaccination, Prevention we already have is not deployed.
- IdeaCommunity-tailored HPV vaccine confidence campaigns with school-based delivery
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Head and neck squamous cell carcinoma.
- IdeaMake a two-minute mouth cancer check part of every dental visit
Shares Prevention we already have is not deployed, Head and neck squamous cell carcinoma.
- IdeaEliminate infection-caused cancers: HPV, hepatitis B and C, H. pylori and EBV
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Head and neck squamous cell carcinoma.
- PersonMu-Sheng Zeng
Shares HPV & HBV vaccination, Head and neck squamous cell carcinoma.
- IdeaSwitch every country to single-dose HPV vaccination and add catch-up to age 26
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Head and neck squamous cell carcinoma.
- Key paperSwedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17
Shares England's HPV programme: cervical cancer down 87% in the first cohort vaccinated at 12-13, HPV & HBV vaccination, Prevention we already have is not deployed, Head and neck squamous cell carcinoma.
- TrialKEN SHE (single-dose HPV vaccine)
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Head and neck squamous cell carcinoma.